06:39 AM EDT, 04/29/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q1 adjusted earnings Tuesday of $8.22 per diluted share, down from $9.55 a year earlier.
Analysts polled by FactSet expected $8.62.
Revenue for the quarter ended March 31 was $3.03 billion, compared with $3.15 billion a year earlier.
Analysts surveyed by FactSet expected $3.25 billion.
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
